Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

Martin, A, Smith, DE, Carr, A, Ringland, C, Amin, J, Emery, S, Hoy, J, Workman, C, Doong, N, Freund, J and Cooper, DA (2004) Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. Aids, 18 7: 1029-1036. doi:10.1097/01.aids.0000125923.10668.da


Author Martin, A
Smith, DE
Carr, A
Ringland, C
Amin, J
Emery, S
Hoy, J
Workman, C
Doong, N
Freund, J
Cooper, DA
Title Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study
Journal name Aids   Check publisher's open access policy
ISSN 0269-9370
Publication date 2004-04-01
Sub-type Article (original research)
DOI 10.1097/01.aids.0000125923.10668.da
Volume 18
Issue 7
Start page 1029
End page 1036
Total pages 8
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language eng
Keyword HIV lipodystrophy
lipoatrophy
thymidine analogues
abacavir
Nucleoside Analogs
Case-Definition
Lipodystrophy
Therapy
Substitution
Inhibitors
48-Week
Cohort
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 218 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 18 Mar 2017, 01:00:47 EST by Web Cron